Sentences with phrase «stock price performance over»

Annual incentive compensation and a portion of performance - based restricted units focus on short - term performance while the balance of performance - based restricted units and the other components of performance - based pay are tied to achievement of financial targets and stock price performance over a longer period of time.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

In addition to a $ 1 million base salary and $ 2 million performance bonus, the Waterloo, Ontario, company will give him 13 million BlackBerry restricted share units, worth $ 85 million based on the current stock price, that will vest over five years.

The view in designing and using OSUs was that they struck a balance between stock options and RSUs; they are performance - based and present significant upside potential for superior stock price performance while sharing some attributes of traditional RSUs by offering some value to the recipient, even if the stock price declines over the three - year measurement period.

On June 9, MSCI Inc., the New York firm whose MSCI Emerging Markets Index is the most widely tracked benchmark of share - price performance outside the developed world, will disclose whether it plans to add mainland Chinese stocks to the index over the coming year.

«Over the intermediate to long - term in the stock market, business performance has been inexorably reflected in share price performance.»

To understand the effect of this modest shortfall in stock selection performance over the past 8 months, recall that when the Fund is hedged against the impact of market fluctuations (and provided that our long - put / short - call index option combinations have identical strike prices and expirations), its returns are roughly equal to:

This should drive consistent comp and EPS out performance and meaningful stock price appreciation from current levels over the next few years.»

«We are willing to endure a high degree of stock price and portfolio volatility because we believe it allows us to achieve a greater degree of investment performance over the long term» Bill Ackman

The stock prices of individual companies can vary significantly over short periods of time, and such price movements are not always correlated with changes in company fundamental performance.

But with great small caps like SoupMan, Labor Smart, Quadrant 4 System increasing revenues and others that are undervalued such as High Performance Beverage, Mondial Ventures, Octagon 88, and Americas Petrogas, investors willing to do the research should do well over the long term when the market eventually fairly prices the stocks.

Performance of the personal lines insurers over the past ten years reflects the relatively hard market through 1997, with strong investment performance through 1999 not getting reflected in stPerformance of the personal lines insurers over the past ten years reflects the relatively hard market through 1997, with strong investment performance through 1999 not getting reflected in stperformance through 1999 not getting reflected in stock prices.

For the NAV investments at discount prices, long - term performance ought to be good enough if the issuer can continue to increase NAV, or if the company engages in resource conversion activities such as getting taken over, liquidating assets, or buying back common stock on a massive scale.

Here, excellent past performance seems likely to be a harbinger of future under - performance insofar as one believes that over the long term, market prices for passively owned common stocks will have a relationship to underlying corporate fundamentals.

Besides, stock prices over the short term are essentially random and over long term are dictated by the fundamentals and the company performance in the future.

The share price has been disappointingly unresponsive to both the improved macroeconomic environment (commodity pricing) and improvements in the operating business; investors seem to be stuck looking backwards at stock performance and commodity pricing over the past 4 or 5 years.

Further research by Tweedy, Browne has indicated that companies satisfying the net current asset criterion have not only enjoyed superior common stock performance over time but also often have been priced at significant discounts to «real world» estimates of the specific value that stockholders would probably receive in an actual sale or liquidation of the entire corporation.

Yuliya Plyakha, Raman Uppal and Grigory Vilkov examine the performance of equal -, value -, and price - weighted portfolios of stocks in the major U.S. equity indices over the last four decades (note that here «value» weight is used in the academic sense, meaning «market capitalization weight»).

Sequoia staked its fate to the performance of Valeant Pharmaceuticals, a firm adored by hedge fund managers and Sequoia — which plowed over a third of its portfolio into the stock — for its singular strategy: buy small drug companies with successful niche medicines, then skyrocket the price of those drugs.

Lastly, the Buffettology stocks have fared better in terms of price performance over the last year.

In periods of sustained rising stock prices, small - cap stocks tend to outperform large - cap stocks; over a longer term, the performance gap persists but narrows.

At times when the yield spread was less than 80 basis points — when REIT dividend yields were extraordinarily high, reflecting REIT stock prices that were especially low relative to current distributions — REIT performance over the next year tended to be especially strong, with total returns that averaged 20.81 percent and outpaced the broad stock market by 5.67 percentage points.

At times when the yield spread was greater than 180 basis points — that is, when REIT dividend yields were extraordinarily low, reflecting REIT stock prices that were especially high relative to their current distributions — REIT performance over the next year tended to be weak, with total returns that averaged 6.98 percent and underperformed the broad stock market by 1.84 percentage points.